Implantable Cardioverter-defibrillators Market

Implantable Cardioverter-defibrillators Market – Global
Industry Insights, Trends, Outlook, and Opportunity
Analysis, 2018-2026
An ICD or implantable cardioverter-defibrillator is a battery-operated device that is placed under
the skin of the patient to monitor the user’s heart rate. ICDs are connected to the heart by thin
wires. In cases where an abnormal heart beat is detected, implantable cardioverter-defibrillator
deliver an electric shock to reinstate a normal heart rhythm if the patient’s heart is beating too
fast. Implantable cardioverter-defibrillators have been useful in thwarting sudden deaths in
patients with fibrillation or sustained ventricular tachycardia. Various studies have shown that
they may prevent cardiac arrest in patients who are at a high risk of life-threatening ventricular
arrhythmias. An implantable cardioverter -defibrillator senses when the heart rhythm is not
normal and it tries to make the heart rhythm normal. If the device has a pacemaker feature
incorporated, it works as a pacemaker when the heartbeat is slow, and transmit tiny electric
signals to the heart. However, when the heartbeat is very chaotic or fast, the device gives
defibrillation shocks in order to restrain the abnormal rhythm. Implantable cardioverterdefibrillators work for 24 hours a day.
Download PDF Brochure Of This Research Report @
According to Centers for Disease Control and Prevention (CDC), it is estimated that around 2.7–
6.1 million individuals in the U.S. suffered from atrial fibrillation in 2015. The report suggests
that the number of occurrences is likely to increase with the increase in number of aging of the
population in this region. Roughly 2% of the population who are younger than 65 years of age
suffers from AF. However, around 9% of the population with 65 years of age or more suffers
from AF. Increasing cases of AF among the global population coupled with advancement in
technology will drive the implantable cardioverter-defibrillators market during the forecast
Report includes chapters which deeply display the following deliverable about industry :
• Implantable Cardioverter-defibrillators Market Research Objective and Assumption
• Implantable Cardioverter-defibrillators Market Purview - Report Description, Executive
Summary, and Coherent Opportunity Map (COM)
• Implantable Cardioverter-defibrillators Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Implantable Cardioverter-defibrillators Market, By Regions
• Implantable Cardioverter-defibrillators Market Competition by Manufacturers including
Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and
Product Type.
• Implantable Cardioverter-defibrillators Market Manufacturers Profiles/Analysis including
Company Basic Information, Manufacturing Base and Its Competitors.
• Implantable Cardioverter-defibrillators Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Implantable Cardioverter-defibrillators Market Forecast including Production, Consumption,
Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Implantable Cardioverter-defibrillators Market Taxonomy
On the basis of type of product, the global market is classified into:
• Biventricular Implantable Cardioverter Defibrillators
• Single Chambered
• Dual Chambered
On the basis of type of procedure, the global market is classified into:
• Subcutaneous Implantable Cardioverter Defibrillators
• Trans-Venous Implantable Cardioverter Defibrillators
On the basis of end user, the global market is classified into:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others
The subcutaneous ICD (S-ICD) is inserted without placing the leads into the heart. The device is
inserted below the left axilla, or armpit in line with the rib cage. The lead connected to the
device is laired under the skin more willingly than inside the heart. Some of the advantages of
the S-ICD are the lack of immediate or long-term complications caused by inserting a lead into
the heart, such as collapse of the lung and perforation of the heart. Subcutaneous implantable
cardioverter defibrillators are the main driver for the global ICD market due to the
aforementioned reasons. The rise in adoption of S-ICDs will propel the overall implantable
cardioverter-defibrillators market in the forecast period.
Inquire Here Before Purchase of Research Report @
Some of the key players operating in the global implantable cardioverter-defibrillators market
are Imricor Medical Systems, Boston Scientific Corporation, Inc., LivaNova PLC Company,
MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, St. Jude Medical, Inc., and
MRI Interventions, Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

An ICD or implantable cardioverter-defibrillator is a battery-operated device that is placed under the skin of the patient to monitor the user’s heart rate.